139 related articles for article (PubMed ID: 2804349)
1. Immunophenotypic analysis of clonogenic cells in acute lymphoblastic leukemia using an in vitro colony assay.
Hudson AM; Makrynikola V; Kabral A; Bradstock KF
Blood; 1989 Nov; 74(6):2112-20. PubMed ID: 2804349
[TBL] [Abstract][Full Text] [Related]
2. Immunophenotype of clonogenic cells in myeloid leukaemia.
Kabral A; Bradstock KF; Grimsley P; Favaloro EJ
Leuk Res; 1988; 12(1):51-9. PubMed ID: 3162752
[TBL] [Abstract][Full Text] [Related]
3. Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1.
Kasai M; Akatsuka Y; Emi N; Taji H; Kohno A; Abe A; Tanimoto M; Kodera Y; Saito H
Int J Hematol; 1999 Feb; 69(2):112-8. PubMed ID: 10071461
[TBL] [Abstract][Full Text] [Related]
4. Pre-clinical evaluation of anti-lacto-N-fucopentaose III (CD15) monoclonal antibodies for ex vivo bone marrow purging in acute myeloid leukemia.
Guyotat D; Shi ZH; Campos L; Rabat M; Bonnier S; Poncelet P; Laurent JC; Fiere D
Bone Marrow Transplant; 1990 Dec; 6(6):385-90. PubMed ID: 1982926
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
[TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic analysis of acute lymphocytic leukemia.
Riley RS; Massey D; Jackson-Cook C; Idowu M; Romagnoli G
Hematol Oncol Clin North Am; 2002 Apr; 16(2):245-99, v. PubMed ID: 12094473
[TBL] [Abstract][Full Text] [Related]
7. Growth requirements for human acute lymphoblastic leukemia cells: refinement of a clonogenic assay.
Estrov Z; Freedman MH
Cancer Res; 1988 Oct; 48(20):5901-7. PubMed ID: 3048651
[TBL] [Abstract][Full Text] [Related]
8. Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.
Uckun FM; Kersey JH; Haake R; Weisdorf D; Ramsay NK
Blood; 1992 Feb; 79(4):1094-104. PubMed ID: 1531306
[TBL] [Abstract][Full Text] [Related]
9. Assay of lymphokine-activated killer activity generated from bone marrow cells of children with acute lymphoblastic leukemia.
Zhou MX; Findley HW; Davis R; Ragab AH
Blood; 1990 Jan; 75(1):160-5. PubMed ID: 2294987
[TBL] [Abstract][Full Text] [Related]
10. Immunophenotypic classification of acute lymphoblastic leukaemia.
Ludwig WD; Raghavachar A; Thiel E
Baillieres Clin Haematol; 1994 Jun; 7(2):235-62. PubMed ID: 7803900
[No Abstract] [Full Text] [Related]
11. Granulocyte-colony stimulating factor, granulocyte-macrophage colony stimulating factor, PIXY-321, stem cell factor, interleukin-3, and interleukin-7: receptor binding and effects on clonogenic proliferation in acute lymphoblastic leukemia.
Drach D; Estrov Z; Zhao S; Drach J; Cork A; Collins D; Kantarjian H; Andreeff M
Leuk Lymphoma; 1994 Dec; 16(1-2):79-88. PubMed ID: 7535143
[TBL] [Abstract][Full Text] [Related]
12. Immunophenotypes in adult acute lymphocytic leukemia. Role of flow cytometry in diagnosis and monitoring of disease.
Huh YO; Ibrahim S
Hematol Oncol Clin North Am; 2000 Dec; 14(6):1251-65. PubMed ID: 11147222
[TBL] [Abstract][Full Text] [Related]
13. Effects of recombinant human cytokines on precursor-B acute lymphoblastic leukemia cells.
Makrynikola V; Kabral A; Bradstock KF
Exp Hematol; 1991 Aug; 19(7):674-9. PubMed ID: 1893954
[TBL] [Abstract][Full Text] [Related]
14. CD10/common acute lymphoblastic leukemia-associated antigen and adhesion factor expression is predictive for lymphokine-activated killing sensitivity of adult B-lineage acute lymphoblastic leukemia.
Correale P; Tagliaferri P; Camera A; Caraglia M; Del Vecchio L; De Laurentis M; Pinto A; Rotoli B; Bianco AR
Year Immunol; 1993; 7():90-5. PubMed ID: 7690510
[No Abstract] [Full Text] [Related]
15. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
16. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
17. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
Rothe G; Schmitz G
Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
[TBL] [Abstract][Full Text] [Related]
18. [Phenotypic changes in refractory and relapse acute lymphoblastic leukemias].
Gómez E; San Miguel JF; González M; Orfao A; Cañizo MC; Ciudad J; López Borrasca A
Sangre (Barc); 1991 Jun; 36(3):201-4. PubMed ID: 1948539
[TBL] [Abstract][Full Text] [Related]
19. Effective purging of bone marrow by a combination of immunorosette depletion and complement lysis.
Slaper-Cortenbach IC; Admiraal LG; van Leeuwen EF; Kerr JM; von dem Borne AE; Tetteroo PA
Exp Hematol; 1990 Jan; 18(1):49-54. PubMed ID: 2298269
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a hierarchy in human acute myeloid leukemia progenitor cells.
Sutherland HJ; Blair A; Zapf RW
Blood; 1996 Jun; 87(11):4754-61. PubMed ID: 8639846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
